Critical Contrast: Assertio (NASDAQ:ASRT) vs. CannaPharmaRX (OTCMKTS:CPMD)
Assertio (NASDAQ:ASRT – Get Free Report) and CannaPharmaRX (OTCMKTS:CPMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations and risk. Insider & Institutional Ownership 49.0% of Assertio shares are […]
More Stories
Wedbush Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $22.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target trimmed by Wedbush from $25.00 to $22.00 in a research...
Oppenheimer Increases Onto Innovation (NYSE:ONTO) Price Target to $275.00
Onto Innovation (NYSE:ONTO – Free Report) had its target price raised by Oppenheimer from $260.00 to $275.00 in a research...
Gritstone bio (NASDAQ:GRTS) Receives Neutral Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Gritstone bio (NASDAQ:GRTS – Free Report) in a report published on...
Evercore ISI Raises KeyCorp (NYSE:KEY) Price Target to $20.00
KeyCorp (NYSE:KEY – Free Report) had its target price lifted by Evercore ISI from $18.50 to $20.00 in a report...
JPMorgan Chase & Co. Begins Coverage on Diamondback Energy (NASDAQ:FANG)
JPMorgan Chase & Co. began coverage on shares of Diamondback Energy (NASDAQ:FANG – Free Report) in a research note published...
Deutsche Bank Aktiengesellschaft Increases BWX Technologies (NYSE:BWXT) Price Target to $129.00
BWX Technologies (NYSE:BWXT – Get Free Report) had its target price raised by equities researchers at Deutsche Bank Aktiengesellschaft from...